Guardian Pharmacy Services ( NYSE:GRDN – Get Free Report ) announced its quarterly earnings data on Thursday. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.02, FiscalAI reports. The business had revenue of $371.07 million during the quarter, compared to analyst estimates of $365.76 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%.
Here are the key takeaways from Guardian Pharmacy Services’ conference call:
Get Guardian Pharmacy Services alerts:
Guardian raised 2026 guidance to revenue of $1.44 billion–$1.46 billion and Adjusted EBITDA of $136 million–$138 million. Third-quarter Adjusted EBITDA rose 24% year over year to $33.9 million, while net income nearly doubled to $19 million.
Reported revenue fell 1.7% to $371 million, primarily due to IRA-related drug price reductions; management said revenue would have grown at a high-single-digit rate without that impact. Prescription volume increased 10% year over year.
Growth efforts include new pharmacy locations and acquisitions, including Nautilus, whose residents were transitioned to Guardian pharmacies and whose ...